Trademarkia Logo

Australia

AU$
HEMAXIP IV
Cancelled: Cancelled at the request of IB

Last updated on 2 Jul 2015

Owner Info

The Medicines Company

8 Sylvan Way

Parsippany, New Jersey 07054, UNITED STATES OF AMERICA

Serial Number

1566632 filed on 31 May 2013

Correspondent

Julia M. Chester, Sidley Austin LLP

717 North Harwood St.,,

Suite 3400,

UNITED STATES OF AMERICA

HEMAXIP IV

Classification Information


Class [005]
Pharmaceutical preparations, namely, a platelet inhibiting drug administered intravenously in a hospital setting to prevent blood clotting leading to Read More

Mark Details


Serial Number

1566632

Registered On

31 May 2013

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

3 Dec 2012

Mark Type

US

Legal History


Show more

Status DateAction Taken
2th Jul 2015Cancellation of Entry in Register Published
29th Jun 2015Cancel IP Right
11th Dec 2014General Correspondence (Application or Registration)
3rd Oct 2013IP Right Registration Published
26th Sept 2013Register Trade Mark
26th Sept 2013Application Status
18th Jul 2013IP Right Acceptance Published
11th Jul 2013IP Right Filed Published
10th Jul 2013Clear Examination report approved
10th Jul 2013Application Accepted correspondence sent